Mylan Investors Ink $60M Deal In Quality Control Suit
Investors in the former Mylan NV have reached a $60 million settlement with the company over claims the drugmaker manipulated quality control measures at a West Virginia facility and lied to...To view the full article, register now.
Already a subscriber? Click here to view full article